Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

NCT00675688 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3544

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Hyperplasia
Osteoporosis

Interventions

DRUG: Bazedoxifene/Conjugate Estrogens (CE)
DRUG: Raloxifene
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer